Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
OTC:IDXG
Price:
1.34 USD
-7.59%
Market Closed
Updated:
May 15, 2024
Interpace Biosciences Inc
Depreciation & Amortization
|
Interpace Biosciences Inc
Depreciation & Amortization Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Interpace Biosciences Inc
OTC:IDXG
|
Depreciation & Amortization
-$861k
|
CAGR 3-Years
42%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Depreciation & Amortization
-$754.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Depreciation & Amortization
-$111m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Depreciation & Amortization
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-42%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Depreciation & Amortization
-$226.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-11%
|
See Also
What is Interpace Biosciences Inc's Depreciation & Amortization?
Depreciation & Amortization
-861k
USD
-861k
USD
Based on the financial report for Dec 31, 2023, Interpace Biosciences Inc's Depreciation & Amortization amounts to -861k USD.
What is Interpace Biosciences Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
25%
25%
Over the last year, the Depreciation & Amortization growth was 34%. The average annual Depreciation & Amortization growth rates for Interpace Biosciences Inc have been 42% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
